National manufacturer of
immunobiological products in Russia
En
National manufacturer of
immunobiological products in Russia

News

Select the desired hashtags

  • RELATOX: New indications for the use in Uzbekistan
    29.07.2024

    RELATOX: New indications for the use in Uzbekistan

    SPA Microgen (part of Nacimbio Holding of Rostec State Corporation) registered four new indications for RELATOX in Uzbekistan.  Now the entire range of uses of this drug is available to consumers from the Republic of Uzbekistan, as in Russia.

    Read more
  • Microgen's preparation for chronic migraines has been approved by the Ministry of Health in Kyrgyzstan
    14.06.2024

    Microgen's preparation for chronic migraines has been approved by the Ministry of Health in Kyrgyzstan

    SPA Microgen (part of Nacimbio Holding of Rostec State Corporation) has received the approval of the Ministry of Health of Kyrgyzstan for the application of the RELATOX drug in the territory of the Republic for two new indications – treatment of chronic migraine and correction of neck wrinkles.

    Read more
  • Botulinum toxin of SPA ‘Microgen’ to treat arm muscle spasticity in patients with neurological diseases
    23.05.2024

    Botulinum toxin of SPA ‘Microgen’ to treat arm muscle spasticity in patients with neurological diseases

    The Russian Ministry of Health has approved the expansion of indications for the use of botulinum toxin type A Relatox by SPA ‘Microgen’ (part of Nacimbio Holding of Rostec State Corporation) for the treatment of focal spasticity of arm muscles in adults.

    Read more
3 of 3 news